Godshalk Welsh Capital Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.88M Sell
11,799
-242
-2% -$56.4K 1.67% 16
2025
Q4
$2.49M Hold
12,041
1.42% 18
2025
Q3
$2.23M Sell
12,041
-65
-0.5% -$11.1K 1.28% 22
2025
Q2
$1.85M Sell
12,106
-325
-3% -$50K 1.14% 25
2025
Q1
$2.06M Buy
12,431
+185
+2% +$28.9K 1.35% 20
2024
Q4
$1.77M Hold
12,246
1.14% 25
2024
Q3
$1.98M Sell
12,246
-200
-2% -$31.9K 1.25% 23
2024
Q2
$1.82M Buy
12,446
+240
+2% +$35.7K 1.21% 25
2024
Q1
$1.93M Sell
12,206
-25
-0.2% -$3.98K 1.3% 23
2023
Q4
$1.92M Sell
12,231
-195
-2% -$29.9K 1.38% 19
2023
Q3
$1.94M Sell
12,426
-575
-4% -$94.9K 1.46% 21
2023
Q2
$2.15M Sell
13,001
-80
-0.6% -$12.9K 1.48% 16
2023
Q1
$2.03M Hold
13,081
1.43% 22
2022
Q4
$2.31M Sell
13,081
-1,309
-9% -$226K 1.69% 13
2022
Q3
$2.35M Buy
14,390
+1,289
+10% +$218K 1.74% 9
2022
Q2
$2.33M Sell
13,101
-165
-1% -$29.4K 1.67% 13
2022
Q1
$2.35M Sell
13,266
-195
-1% -$33.2K 1.44% 15
2021
Q4
$2.3M Sell
13,461
-225
-2% -$36.8K 1.31% 23
2021
Q3
$2.21M Sell
13,686
-100
-0.7% -$17.1K 1.38% 22
2021
Q2
$2.34M Sell
13,786
-175
-1% -$29K 1.45% 20
2021
Q1
$2.29M Sell
13,961
-100
-0.7% -$16.2K 1.6% 15
2020
Q4
$2.21M Sell
14,061
-160
-1% -$23.6K 1.63% 12
2020
Q3
$2.12M Buy
14,221
+725
+5% +$107K 1.79% 12
2020
Q2
$1.9M Sell
13,496
-185
-1% -$27K 1.78% 14
2020
Q1
$1.79M Sell
13,681
-400
-3% -$56.8K 1.95% 10
2019
Q4
$2.05M Buy
14,081
+100
+0.7% +$13.6K 1.69% 15
2019
Q3
$1.81M Buy
13,981
+281
+2% +$37K 1.6% 18
2019
Q2
$1.91M Buy
13,700
+60
+0.4% +$8.3K 1.76% 17
2019
Q1
$1.91M Sell
13,640
-207
-1% -$27.7K 1.83% 13
2018
Q4
$1.79M Buy
13,847
+172
+1% +$24K 2% 9
2018
Q3
$1.89M Sell
13,675
-500
-4% -$66.4K 1.84% 11
2018
Q2
$1.72M Sell
14,175
-125
-0.9% -$15.6K 1.8% 13
2018
Q1
$1.83M Sell
14,300
-200
-1% -$27K 1.98% 9
2017
Q4
$2.03M Sell
14,500
-400
-3% -$55.7K 2.05% 6
2017
Q3
$1.94M Sell
14,900
-1,025
-6% -$136K 1.94% 6
2017
Q2
$2.11M Sell
15,925
-450
-3% -$57.4K 2.09% 6
2017
Q1
$2.04M Sell
16,375
-350
-2% -$41.8K 2% 7
2016
Q4
$1.93M Sell
16,725
-325
-2% -$37.5K 1.97% 5
2016
Q3
$2.01M Buy
17,050
+47
+0.3% +$5.7K 2.08% 3
2016
Q2
$2.06M Sell
17,003
-400
-2% -$45.5K 2.17% 3
2016
Q1
$1.88M Sell
17,403
-250
-1% -$25.9K 1.95% 5
2015
Q4
$1.81M Hold
17,653
1.89% 7
2015
Q3
$1.65M Buy
17,653
+6
+0% +$580 1.8% 7
2015
Q2
$1.72M Sell
17,647
-100
-0.6% -$10K 1.75% 8
2015
Q1
$1.78M Buy
17,747
+169
+1% +$17.2K 1.83% 8
2014
Q4
$1.84M Buy
+17,578
New +$1.85M 1.67% 9

Other funds holding JNJ

Godshalk Welsh Capital Management's JNJ Position: Q1 2026 in Review

Godshalk Welsh Capital Management reduced its Johnson & Johnson (JNJ) stake by 2% in Q1 2026, selling an estimated $56.4K and leaving 11,799 shares worth $2.88M. The position accounts for 1.67% of the portfolio, ranked #16.

Godshalk Welsh Capital Management first reported a position in JNJ in Q4 2014 and has held it in 46 quarters since. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Godshalk Welsh Capital Management held 11,799 shares of Johnson & Johnson worth $2.88M as of Q1 2026.
  • Godshalk Welsh Capital Management sold 242 Johnson & Johnson shares in Q1 2026, an estimated $56.4K.
  • Johnson & Johnson made up 1.67% of Godshalk Welsh Capital Management's portfolio in Q1 2026, its #16 holding.
  • Godshalk Welsh Capital Management first reported a position in Johnson & Johnson in Q4 2014 and has held it in 46 quarters since.
  • 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Godshalk Welsh Capital Management's 13F filing for Q1 2026, filed 13 May 2026.